A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, Both With Insulin Aspart as Mealtime Insulin in Subjects With Type 1 Diabetes
Clinical trial NCT02034513 · COMPLETED
Trial details
- NCT number
- NCT02034513
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-05
- Primary completion
- 2016-01-11
- Enrollment
- 501
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.